Comparison of fenofibrate–mesoporous silica drug-loading processes for enhanced drug delivery

Ahern, Robert J.; Hanrahan, John P.; Tobin, Joseph M.; Ryan, Katie B.; Crean, Abina M.

doi:10.1016/j.ejps.2013.08.026

Cited by 102 publications

(50 citation statements)

References 56 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…supercritical carbon dioxide) has yielded mesoporous materials with improved encapsulation properties. The supercritical fluid mediums liquid like density allows solubilisation of large quantities of drug and in tandem gas like diffusivity facilitates molecular access to the mesoporous matrix (129,181). Moreover, this process does not require solvent removal steps commonly associated with process involving organic solvents.…”

Section: Drug Loading Methods For Mesoporous Materialsmentioning

confidence: 99%

“…In addition these conventional methods have intrinsic disadvantages such as the use of organic solvents that will require a subsequent solvent elimination process; impacting on time and cost factors (129). Therefore, supplementary approaches have been proposed to load drug into mesoporous carriers without affecting active stability such as supercritical fluids method (129,181), co-spray drying (182,183) and microwave irradiation (184). The supercritical fluid method (e.g.…”

Section: Drug Loading Methods For Mesoporous Materialsmentioning

confidence: 99%

See 1 more Smart Citation

Porous Inorganic Drug Delivery Systems—a Review

et al. 2017

View full text Add to dashboard Cite

Innovative methods and materials have been developed to overcome limitations associated with current drug delivery systems. Significant developments have led to the use of a variety of materials (as excipients) such as inorganic and metallic structures; marking a transition from conventional polymers. Inorganic materials, especially those possessing significant porosity, are emerging as good candidates for the delivery of a range of drugs (anti-biotics, anti-cancer and anti-inflammatories), providing several advantages in formulation and engineering (encapsulation of drug in amorphous form, controlled delivery and improved targeting). This review focuses on key selected developments in porous drug delivery systems. The review provides a short broad overview of porous polymeric materials for drug delivery before focusing on porous inorganic materials (e.g. Santa Barbara Amorphous (SBA) and Mobil Composition of Matter (MCM)) and their utilisation in drug dosage form development. Methods for their preparation and drug loading thereafter are detailed. Several examples of porous inorganic materials, drugs used and outcomes are discussed providing the reader with an understanding of advances in the field and realistic opportunities.

show abstract

Section: Drug Loading Methods For Mesoporous Materialsmentioning

confidence: 99%

Section: Drug Loading Methods For Mesoporous Materialsmentioning

confidence: 99%

Porous Inorganic Drug Delivery Systems—a Review

et al. 2017

View full text Add to dashboard Cite

show abstract

“…26 The PXRD patterns of PTX, DOX, HCP, LCP, PTX-LCP, DOX-LCP, PTX/DOX-LCP and the same proportion of PM are shown in Figure 3B. PTX and DOX displayed many diffraction peaks, which indicated that PTX and DOX were crystalline drugs.…”

Section: Pxrd Dsc and Ftir Characterizationmentioning

confidence: 99%

Application of a lipid-coated hollow calcium phosphate nanoparticle in synergistic co-delivery of doxorubicin and paclitaxel for the treatment of human lung cancer A549 cells

Hao

et al. 2017

IJN

View full text Add to dashboard Cite

In this study, we developed a lipid-coated hollow calcium phosphate (LCP) nanoparticle for the combined application of two chemotherapeutic drugs to human lung cancer A549 cells. Hydrophilic doxorubicin (DOX) was incorporated into the hollow structure of hollow calcium phosphate (HCP), and a lipid bilayer containing hydrophobic paclitaxel (PTX) was subsequently coated on the surface of HCP. The study on combinational effects demonstrated that the combination of DOX and PTX at a mass ratio of 12:1 showed a synergistic effect against A549 cells. The particle size, zeta potential, and encapsulation efficiency were measured to obtain optimal values: particle size was 335.0 3.2 nm, zeta potential −41.1 mV, and encapsulation efficiency 80.40%±2.24%. An in vitro release study indicated that LCP produced a sustained drug release. A549 cells had a better uptake of LCP with good biocompatibility. Furthermore, in vitro cytotoxicity experiment, apoptosis analysis, in vivo anti-tumor efficacy and protein expression analysis of Bax, Bcl-2, and Caspase-3 demonstrated that the co-delivery system based on LCP had significant synergistic anti-tumor activity. All conclusions suggested that LCP is a promising platform for co-delivery of multiple anti-tumor drugs.

show abstract

“…Fenofibrate, a drug that is poorly soluble in water, was loaded onto SBA-15 using the following methods: The obtained results described in (Table 1). All the processing methods enhanced the release of the drug compared with the unprocessed drug [47]. Coating drug-loaded core particles with a polymer film is one of the most widely investigated technologies in making multi-particulate dosage forms.…”

Section: Methods Of Drug Loading For Msnsmentioning

confidence: 99%

Mesoporous Silica Nanoparticles (MSN): A Nanonetwork and Hierarchical Structure in Drug Delivery

Jadhav¹

2015

JNMR

View full text Add to dashboard Cite

Chemistry, synthesis and functionalization of MSNsWith an abundant availability of various types of surfactants and the development of a deep understanding of sol-gel chemistry, MSNs with different structures have been developed. The size, morphology, pore size and pore structure of MSNs can be rationally designed and the synthesis process can be freely AbstractNanotechnology is a fast-growing area, involving the fabrication and use of nano-sized materials and devices. Nanocomposite materials play a number of important roles in modern science and technology, including pharmaceutical science. Mesoporous materials in particular have a large number of applications. In the past decade, mesoporous silica nanoparticles (MSNs) attracted attention increasingly for their potential biomedical applications. With their tailored mesoporous structure and high surface area, MSNs have significant advantages as drug delivery systems (DDSs) compared with traditional drug nanocarriers. Inorganic mesoporous materials are being used increasingly in pharmaceutical materials research to enhance the dissolution and permeation behavior of drugs that are poorly soluble in water. The benefits of using mesoporous materials in drug delivery applications stem from their large surface area and pore volume. These properties enable the materials to accommodate large amounts of payload molecules, protect them from premature degradation and promote controlled and fast release. As carriers with various morphologies and chemical surface properties can be produced, these materials may even promote adsorption from the gastrointestinal tract to the systemic circulation. In this work, we review recent progress in the synthesis and surface functionalization of MSNs for drug delivery applications.

show abstract

Comparison of fenofibrate–mesoporous silica drug-loading processes for enhanced drug delivery

Cited by 102 publications

References 56 publications

Porous Inorganic Drug Delivery Systems—a Review

Porous Inorganic Drug Delivery Systems—a Review

Application of a lipid-coated hollow calcium phosphate nanoparticle in synergistic co-delivery of doxorubicin and paclitaxel for the treatment of human lung cancer A549 cells

Mesoporous Silica Nanoparticles (MSN): A Nanonetwork and Hierarchical Structure in Drug Delivery

Contact Info

Product

Resources

About